Emotive has launched a dedicated Advanced Therapies Business Unit, which will be headed up by Dr Germano Ferrari, an expert in cell and gene therapies.
He will be joining Emotive following 20 years’ in research as well as holding medical affairs and commercial roles within biopharma and diagnostics.
He will also become vice president of advanced therapies to oversee the new business unit. With a PhD in Biotechnology along with an MBA, Germano is an expert in cell and gene therapies as well as having research experience in haematology. He previously spent 18 years in a variety of medical affairs and commercial roles at biopharma and diagnostics and then as a Programme Manager at the UK’s Cell and Gene Therapy Catapult where he helped develop commercialisation pathways for several pre-clinical AT products.
Dr Ferrari said of his new role, “I am honoured to work with the emotive team in this challenging and rewarding environment to help biopharmaceutical companies involved in this innovative area bring life-changing therapies to the patients”.
